Triglyceride-glucose index: a novel assessment tool for all-cause mortality in critical stroke patients—a retrospective analysis of the eICU-CRD database

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

TyG shows stronger correlations with short-term ICU and in-hospital mortality in critically ill stroke patients compared to AIP and TC_HDL. Monitoring TyG may aid prognostic assessment and risk stratification, supporting optimized treatment strategies and aligning with prior research on TyG and stroke outcomes.

Study context

Population
ICU-admitted stroke patients (ischemic, hemorrhagic, subarachnoid) from the eICU-CRDscreened
Participants
3,247 patients
Exposure
Higher vs lower TyG, atherogenic index of plasma (AIP) and TC_HDL quartiles
Outcome
In-hospital and ICU mortality
Methodological detailseICU-CRD database
  • eICU-CRD database

Main finding

As reported in the abstract

In-hospital mortality rate

17.2%

ICU mortality rate

9.7%

Elevated TyG and ICU mortality (multivariate Cox), HR

1.528, 95% CI 1.252-1.771

P = 0.002

Elevated TyG and in-hospital mortality (multivariate Cox), HR

1.434, 95% CI 1.04-1.619

P = 0.013

Observational data: associations, not effects.

Further findings

AIP and mortality

Elevated AIP and ICU mortality, HR
1.342, P = 0.021
Elevated AIP and in-hospital mortality, HR
1.631, P = 0.005
Kaplan-Meier confirmed AIP's association with in-hospital mortality

TC_HDL and mortality

TC_HDL showed no significant associations

TyG: Kaplan-Meier and restricted cubic splines

Kaplan-Meier confirmed TyG's links to both mortalities; risk increased with higher TyG

Original publication

Triglyceride-glucose index: a novel assessment tool for all-cause mortality in critical stroke patients—a retrospective analysis of the eICU-CRD database. Cardiovasc Diabetol. Published 26 July 2025. doi:10.1186/s12933-025-02872-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.